View on Pubmed.gov 9951682 | View on doi.org 10.1007/BF02787...
Oligoclonal T cells in human cancer.
- deCODE Genetics Inc., Reykjavik, Iceland. evah@decode.is
Abstract
Many solid tumors are characterised by the infiltration of lymphocytes and their presence has been correlated with a more favourable prognosis. These tumor-infiltrating lymphocytes (TIL), have been shown to possess specific cytolytic reactivity towards autologous tumours, thus suggesting that tumour cells may express antigens capable of eliciting an immune response. Expression of such tumour-associated antigens (TAA) in combination with appropriate accessory signals would lead to the in vivo accumulation of T cells with anti-tumour specificity. Analysis of the composition of the specific T-cell receptor (TCR) of TIL could thus provide information on the nature of the antigen(s) recognised by TIL. In this review, different aspects of the presence of clonal T cells in patients with cancer are discussed.
References
Blood. 1996 Apr 15;87(8):3297-306
Leukemia. 1997 Aug;11(8):1312-7
J Immunol. 1994 May 15;152(10):4993-9
Science. 1996 Jun 21;272(5269):1755-62
Cited by 22 citations (total)
Journal Article
Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer.
Electronic publication date January 5, 2002
E Song [...] U Heemann et al.
Expression of membrane-bound Fas ligand (mFasL) on colon cancer cells serves as a potential mechanism to inhibit host immune function...
Journal Article Research Support, Non-U.S. Gov't
Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin.
Electronic publication date March 2, 2010
Zhi-Yu Xiao [...] He-Rui Yao et al.
AIM
To investigate whether silencing Fas-associated phosphatase 1 (FAP-1) expression enhances the efficiency of chemotherapy for colon carcinoma with oxaliplatin.
METHODS
Expression of...